Abstract:
:We describe here the design, synthesis, molecular modeling, and biological evaluation of a series of small molecule, nonpeptide inhibitors of SARS-CoV PLpro. Our initial lead compound was identified via high-throughput screening of a diverse chemical library. We subsequently carried out structure-activity relationship studies and optimized the lead structure to potent inhibitors that have shown antiviral activity against SARS-CoV infected Vero E6 cells. Upon the basis of the X-ray crystal structure of inhibitor 24-bound to SARS-CoV PLpro, a drug design template was created. Our structure-based modification led to the design of a more potent inhibitor, 2 (enzyme IC(50) = 0.46 microM; antiviral EC(50) = 6 microM). Interestingly, its methylamine derivative, 49, displayed good enzyme inhibitory potency (IC(50) = 1.3 microM) and the most potent SARS antiviral activity (EC(50) = 5.2 microM) in the series. We have carried out computational docking studies and generated a predictive 3D-QSAR model for SARS-CoV PLpro inhibitors.
journal_name
J Med Chemjournal_title
Journal of medicinal chemistryauthors
Ghosh AK,Takayama J,Aubin Y,Ratia K,Chaudhuri R,Baez Y,Sleeman K,Coughlin M,Nichols DB,Mulhearn DC,Prabhakar BS,Baker SC,Johnson ME,Mesecar ADdoi
10.1021/jm900611tsubject
Has Abstractpub_date
2009-08-27 00:00:00pages
5228-40issue
16eissn
0022-2623issn
1520-4804journal_volume
52pub_type
杂志文章abstract::Potent and selective inhibitors of Dyrk1B kinase were developed to explore the hypothesis, based on siRNA studies, that Dyrk1B may be a resistance mechanism in cells undergoing a stress response. ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.5b00098
更新日期:2015-03-26 00:00:00
abstract::A variety of N-(aminoalkanoyl)-S-acylcysteamine and N,N'-bis(aminoalkanoyl)cystamine salt derivatives were synthesized. Toxicity and radioprotective activity (as the dose reduction factor DRF) were determined in vivo on mice and compared to WR 2721 and S-acetylcysteamine hydrochloride. One of the most interesting comp...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00161a015
更新日期:1986-11-01 00:00:00
abstract::We have introduced topographical constraints at the 9 position of a superpotent cyclic alpha-melanotropin analogue, Ac-Nle4-Asp5-His6-DPhe7-Arg8-Trp9-Lys10-NH2, by incorporating a methyl group at the beta-carbon of Trp9. These studies were performed on the Trp side chain pharmacophore to identify the bioactive topogra...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00023a012
更新日期:1995-11-10 00:00:00
abstract::Antibiotic resistance is one of the biggest threats to public health, and new antibacterial agents hence are in an urgent need to combat infectious diseases caused by multidrug-resistant (MDR) pathogens. Utilizing dimerization strategy, we rationally designed and efficiently synthesized a new series of small molecule ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.7b01704
更新日期:2018-04-12 00:00:00
abstract::We recently described a number of inhibitors of P450(17 alpha), the key enzyme of androgen biosynthesis. Here, we report the synthesis and activity of novel 17-imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives as potential agents for the treatment of prostatic cancer. A number of 17-(4'-Imidazolyl) derivati...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm970337k
更新日期:1997-09-26 00:00:00
abstract::A new quadruplex motif located in the promoter of the human KRAS gene, within a nuclease hypersensitive element (NHE), has been characterized. Oligonucleotides mimicking this quadruplex are found to compete with a DNA-protein complex between NHE and a nuclear extract from pancreatic cancer cells. When modified with (R...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm800874t
更新日期:2009-01-22 00:00:00
abstract::Epigenetic regulators that exhibit aberrant enzymatic activities or expression profiles are potential therapeutic targets for cancers. Specifically, enzymes responsible for methylation at histone-3 lysine-9 (like G9a) and aberrant DNA hypermethylation (DNMTs) have been implicated in a number of cancers. Recently, mole...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.7b01925
更新日期:2018-08-09 00:00:00
abstract::Upon the basis of The Cancer Genome Atlas (TCGA) data set, we identified that several autophagy-related proteins such as AMP-activated protein kinase (AMPK) were remarkably downregulated in breast cancer. Combined with coimmunoprecipitation assay, we demonstrated that BRD4 might interact with AMPK. After analyses of t...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/acs.jmedchem.7b00275
更新日期:2017-12-28 00:00:00
abstract::Bufotenine (5-hydroxy-N,N-dimethyltryptamine) has been reported to be behaviorally inactive or only very weakly active in man and animals; this may be a consequence of its low partition coefficient and resultant inability to penetrate the blood--brain barrier. The acetyl, propionyl, butyryl, isobutyryl, and pivalyl es...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00197a025
更新日期:1979-11-01 00:00:00
abstract::Monosubstituted derivatives of adenosine 5'-phosphate (AMP) with substituents of 1-3 atoms or group replacements at any of 11 positions have been synthesized and examined as substrates and inhibitors of the rat muscle adenylate kinase isozyme (AK-M), and the rat AK II and III isozymes predominant in poorly differentia...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00349a008
更新日期:1982-07-01 00:00:00
abstract::Intrigued by the role of protein acetylation in hepatitis C virus (HCV) replication, we tested known histone deacetylase (HDAC) inhibitors and a focused library of structurally simple hydroxamic acids for inhibition of a HCV subgenomic replicon. While known HDAC inhibitors with varied inhibitory profiles proved to be ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm501330g
更新日期:2015-01-22 00:00:00
abstract::A series of imidazo[1,2-b]thiazole derivatives is shown to activate the NAD(+)-dependent deacetylase SIRT1, a potential new therapeutic target to treat various metabolic disorders. This series of compounds was derived from a high throughput screening hit bearing an oxazolopyridine core. Water-solubilizing groups could...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm8012954
更新日期:2009-03-12 00:00:00
abstract::A variety of nitroheterocyclic carbamate prodrugs of phenylenediamine mustard and 5-amino-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydro-3H-benz[e]indoline (amino-seco-CBI-TMI), covering a wide range of reduction potential, were prepared and evaluated for use in gene-directed enzyme prodrug ther...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm030308b
更新日期:2003-12-04 00:00:00
abstract::The principle of bioisosterism-similarly shaped molecules are more likely to share biological properties than are other molecules-has long helped to guide drug discovery. An algorithmic implementation of this principle, based on shape comparisons of a single rule-generated "topomer" conformation per molecule, had been...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm990159q
更新日期:1999-09-23 00:00:00
abstract::In the past few years sirtuins have gained growing attention for their involvement in many biological processes such as cellular metabolism, apoptosis, aging and inflammation. In this contribution, we report the synthesis of a library of thioacetylated pseudopeptides that were screened against human sirtuins 1-3 to re...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm400438k
更新日期:2013-09-12 00:00:00
abstract::Indolic N-benzylation of naltrindole reportedly extends the duration of delta-opioid receptor (DOR) antagonism. Similar modification of the kappa-opioid receptor (KOR) antagonist norBNI (1a) and its 17,17'-diNMe analogue (1d), a low potency mu-opioid receptor (MOR) partial agonist, was found to affect predominantly th...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm049172n
更新日期:2005-03-10 00:00:00
abstract::Analogues of [Leu10]NKA4-10 were synthesized in which each of the amide bonds was sequentially replaced with the reduced amide psi (CH2NH) bond to determine the effect of this structural modification on the antagonism of NKA binding to the HUB NK2 receptor. [psi (CH2-NH)9,Leu10]NKA4-10 (6) retained significant affinit...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00099a024
更新日期:1992-10-16 00:00:00
abstract::Doxazolidine (doxaz) is a new anthracycline anticancer agent. While structurally similar to doxorubicin (dox), doxaz acts via a distinct mechanism to selectively enhance anticancer activity over cardiotoxicity, the most significant clinical impediment to successful anthracycline treatment. Here, we describe the synthe...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm300714p
更新日期:2012-07-26 00:00:00
abstract::Cancer cell targeting peptides have emerged as a highly efficient approach for selective delivery of chemotherapeutics and diagnostics to different cancer cells. However, the use of α-peptides in pharmaceutical applications is hindered by their enzymatic degradation and low bioavailability. Starting with a 10-mer α-pe...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm200750x
更新日期:2011-11-10 00:00:00
abstract::A small library of boron-cluster- and metallacarborane-cluster-based ligands was designed, prepared, and tested for isoform-selective activation or inhibition of the three nitric oxide synthase isoforms. On the basis of the concept of creating a hydrophobic analogue of a natural substrate, a stable and nontoxic basic ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm300805x
更新日期:2012-11-26 00:00:00
abstract::Compound 7 was identified as a potent (IC50 = 14 nM), selective, and orally bioavailable (F = 70% in mouse) inhibitor of protein kinase B/Akt. While promising efficacy was observed in vivo, this compound showed effects on depolarization of Purkinje fibers in an in vitro assay and CV hypotension in vivo. Guided by an X...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm0701019
更新日期:2007-06-28 00:00:00
abstract::Condensation of cyanothioacetamide (4) with ethyl alpha-(ethoxymethylene)acetoacetate (5b), ethyl 4-ethoxy-2-(ethoxymethylene)-3-oxobutanoate (5c), ethyl 2-(ethoxymethylene)-3-oxo-4-phenylpropanoate (5d) afforded exclusively the corresponding 6-substituted pyridines (6b-d). Cyclization of 4 with 3-carbethoxybutane-2,4...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00401a023
更新日期:1988-06-01 00:00:00
abstract::Prealbumin is a major thyroxine binding protein in blood that has been well studied crystallographically and has also been proposed as a model for the thyroxine nuclear receptor in tissue. The high-affinity T4 binding site in prealbumin gave a linear plot on Scatchard analysis. The interactions of selected polychlorin...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00155a010
更新日期:1986-05-01 00:00:00
abstract::Protein arginine methyltransferases (PRMTs) play an important role in diverse biological processes. Among the nine known human PRMTs, PRMT3 has been implicated in ribosomal biosynthesis via asymmetric dimethylation of the 40S ribosomal protein S2 and in cancer via interaction with the DAL-1 tumor suppressor protein. H...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm3018332
更新日期:2013-03-14 00:00:00
abstract::A new high-affinity thyroid hormone antagonist 6 with druglike properties was designed and synthesized. The compound behaved as an antagonist in a cell transactivation assay, and in a first in vivo experiment in rats. ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm060521i
更新日期:2006-11-16 00:00:00
abstract::Dihydropyrimidinones such as compound 12 exhibited high binding affinity and subtype selectivity for the cloned human alpha(1a) receptor. Systematic modifications of 12 led to identification of highly potent and subtype-selective compounds such as (+)-30 and (+)-103, with high binding affinity (K(i) = 0.2 nM) for alph...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm990200p
更新日期:1999-11-18 00:00:00
abstract::Protein arginine methylation is a posttranslational modification critical for a variety of biological processes. Misregulation of protein arginine methyltransferases (PRMTs) has been linked to many pathological conditions. Most current PRMT inhibitors display limited specificity and selectivity, indiscriminately targe...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm401884z
更新日期:2014-03-27 00:00:00
abstract::In an effort to explore structural features affecting receptor recognition in a series of conformationally restricted tetrapeptides related to the cyclic, delta opioid receptor-selective analogue, [formula: see text] electronic, lipophilic, and steric effects at the Phe3 residue were assessed by substitution at differ...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00087a006
更新日期:1992-05-01 00:00:00
abstract::Several optically active N-(indol-3-ylglyoxylyl)amino acid derivatives were synthesized and tested for [3H]flunitrazepam displacing activity in bovine brain membranes. IC50 values were measured and revealed that the D form of the amino acid moiety of the compounds was more potent than both the L form and racemic form,...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm00132a004
更新日期:1989-12-01 00:00:00
abstract::We have previously described a cyclic tetrapeptide, 1, that displays μ opioid receptor (MOPr) agonist and δ opioid receptor (DOPr) antagonist activity, a profile associated with a reduced incidence of opioid tolerance and dependence. Like many peptides, 1 has poor bioavailability. We describe here an analogue of 1 wit...
journal_title:Journal of medicinal chemistry
pub_type: 杂志文章
doi:10.1021/jm5002088
更新日期:2014-04-10 00:00:00